Suboptimal etravirine activity is common during failure of nevirapine-based combination antiretroviral therapy in a cohort infected with non-B subtype HIV-1.

Taiwo, Babafemi; Chaplin, Beth; Penugonda, Sudhir; Meloni, Seema; Akanmu, Sulaimon; Gashau, Wadzani; Idoko, John; Adewole, Isaac; Murphy, Robert; Kanki, Phyllis

Taiwo, Babafemi; Chaplin, Beth; Penugonda, Sudhir; Meloni, Seema; Akanmu, Sulaimon; Gashau, Wadzani; Idoko, John; Adewole, Isaac; Murphy, Robert; Kanki, Phyllis.

Affiliation

Taiwo B; Northwestern University Feinberg School of Medicine, Infectious Diseases Division, Chicago, IL 60611, USA. b-taiwo@northwestern.edu

Curr HIV Res ; 8(3): 194-8, 2010 Apr.

Article in En | MEDLINE | ID: mdl-20163340

Subject(s)

Anti-HIV Agents/therapeutic use; Antiretroviral Therapy, Highly Active/methods; HIV Infections/drug therapy; HIV-1/classification; Nevirapine/therapeutic use; Pyridazines/therapeutic use; Adult; Anti-HIV Agents/pharmacology; Drug Resistance, Viral; Female; Genotype; HIV Infections/virology; HIV-1/genetics; HIV-1/isolation & purification; Humans; Male; Nevirapine/pharmacology; Nitriles; Pyridazines/pharmacology; Pyrimidines; Treatment Failure; Viral Load; Viral Proteins/genetics

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Pyridazines / HIV Infections / HIV-1 / Anti-HIV Agents / Nevirapine / Antiretroviral Therapy, Highly Active Type of study: Guideline / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: Curr HIV Res Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2010 Type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links